drugset / Trial / NCT03339622

Safety and Efficacy of Smoked Cannabis for Improving Quality of Life in Advanced Cancer Patients

NCT03339622

Phase 3 Terminated 8 enrolled Tetra Bio-Pharma
RandomizedParallel-groupTriple-blindTreatment

Summary

Cancer causes pain in many of the patients that it affects. Physicians specialized in palliative care help advanced cancer patients to maintain as good pain control as possible through the use of medications such as opioids. Even with palliative care and optimal use of medications, many patients still suffer enormously as the cancer spreads. Because of this, some cancer patients also try or use cannabis in different ways to relieve their pain and improve the way they feel. However, there has not been much high-quality research done yet to prove whether or not cannabis products are truly useful to relieve severe cancer pain. This study is to test if advanced cancer patients who use inhaled medical cannabis (PPP001), in addition to palliative care management, will experience improvement in quality of life and relieve uncontrolled pain, providing safety conditions.

Timeline

Start
2018-03-29
Primary completion
2018-12-17
Completion
2019-02-08

Drugs

EvaluationDrugModalityDoseRoute
Subject PPP001 Traditional medicine (herbal / TCM) 280 mg Inhaled

Indications